Epidemiology
- UNRWA: Gaza polio vaccination coverage has reached 90%
16 Sep, 2024 - North Korea launches biggest vaccination drive since Covid after children left unprotected
16 Sep, 2024 - Taliban have suspended polio vaccination campaigns in Afghanistan: UN
16 Sep, 2024 - Humanitarian Pause In Gaza: Polio Vaccination Effort Exposes Deeper Health Crisis
15 Sep, 2024 - Global Experts Sound Alarm: Immediate Action Is Needed in Order To Prevent an H5N1 Pandemic
15 Sep, 2024 - India’s Chikungunya Outbreak Approaches Another Unfortunate Record
15 Sep, 2024 - VIDEO Massive spike in whooping cough cases prompts calls for urgent vaccination
15 Sep, 2024 - According to WHO, more than 90% of children in Gaza have received the first dose of the polio vaccine
14 Sep, 2024 - DRC to launch first phase of Mpox vaccination campaign amid ongoing outbreak
14 Sep, 2024 - Tennessee Reports First Measles Case Since 2019
14 Sep, 2024 - Vaccine shortfall risks spread of deadly new mpox strain
13 Sep, 2024 - COVID-19 vaccines prevented millions of deaths across Latin America and the Caribbean, study shows
13 Sep, 2024 - Brazil faces new wave of the pandemic amid shortage of COVID-19 vaccines
13 Sep, 2024 - Pakistan Seemed Close to Beating Polio. Now It’s Spreading Quickly.
13 Sep, 2024
- Mpox deaths rise by 107 in a week as Africa CDC calls the toll unacceptable
12 Sep, 2024 - New-Onset ANCA-Positive Vasculitis a Rare Complication of COVID-19 Vaccination
12 Sep, 2024 - Australians urged to get whooping cough vaccination as infections rise more than tenfold in year
12 Sep, 2024 - Single Dose of Mpox Vaccine Series Appears to Give Partial Protection
12 Sep, 2024 - Report: RSV vaccines most cost-effective, effective in older adults over 70
11 Sep, 2024 - Whooping cough cases on the rise as the vaccine-preventable disease resurges globally
11 Sep, 2024 - Influenza and COVID outbreaks in a more vaccine hesitant H-N
11 Sep, 2024 - Nine out of ten babies vaccinated against bronchiolitis during first campaign in Spain
11 Sep, 2024 - CDC: Rotavirus vaccine 78% effective against serious illness in preschoolers, 53% in older kids
11 Sep, 2024
- Evaluating the direct effect of vaccination and non-pharmaceutical interventions during the COVID-19 pandemic in Europe
11 Sep, 2024 - One Bavarian Nordic Shot 58% Effective Against Mpox, Study Shows
11 Sep, 2024 - Rotavirus Vaccine Found 78% Effective Against Disease in Nursery School Students
11 Sep, 2024 - Meet the global oral cholera vaccine stockpile
10 Sep, 2024 - NCDHHS urging vaccinations after confirmation of first measles case in North Carolina since 2018
10 Sep, 2024 - Why the spread of mpox is a concern and what caused the delay in vaccines reaching Africa
10 Sep, 2024 - Argentina Launches Aggressive Dengue Prevention Program with 500,000 Vaccines
10 Sep, 2024 - Risk factors, vaccines’ role and what else to know as a whooping cough outbreak grows in Anchorage
10 Sep, 2024 - Whooping Cough Cases Rise In U.S. Following Pattern Seen Worldwide
10 Sep, 2024 - Study highlights key role of COVID-19 boosters in preventing serious illness
09 Sep, 2024 - Study reveals improved COVID-19-associated VTE outcomes in post-vaccine period
09 Sep, 2024
Research
- COVID-19 Vaccination Protects Against Adverse Mental Health Impacts Of Virus
15 Sep, 2024 - Cancer Breakthrough: New Vaccine Stops Tumours In Their Tracks, Prevents New Disease
15 Sep, 2024 - We’re Closer Than Ever To Solving Mystery Of Deadly Virus
14 Sep, 2024 - Evolution of vaccine adjuvants from empirical discovery to rational design
14 Sep, 2024 - New Type of “Self-Amplifying” RNA Could Revolutionize Cancer Treatments
13 Sep, 2024 - Elevated body mass index is not significantly associated with reduced influenza vaccine effectiveness
13 Sep, 2024 - For Which Adults Are RSV Vaccinations Cost-Effective?
13 Sep, 2024 - Promising Lassa Fever Vaccine Prevents Disease and Death in Preclinical Animal Models
13 Sep, 2024 - Risk benefit analysis to evaluate risk of thromboembolic events after mRNA COVID-19 vaccination and COVID-19
13 Sep, 2024 - University in China, which allegedly triggered Covid-19 outbreak, comes up with nasal vaccine to stop futu
12 Sep, 2024 - Study offers insights into potential for vaccine for hepatitis C
12 Sep, 2024 - A new type of RNA could enhance vaccines and cancer treatments
11 Sep, 2024 - COVID-19 mRNA vaccine linked to myocardial scarring in adolescents and young adults
11 Sep, 2024 - Alterations in the plasma proteome persist ten months after recovery from mild to moderate SARS-CoV-2 infection
11 Sep, 2024 - Smart Living: Breast cancer survivor creates organization to develop vaccine
10 Sep, 2024 - Lynchvax: Vaccine hope for cancer risk genetic disorder
10 Sep, 2024 - TFF Pharmaceuticals announces preclinical data from influenza vaccine candidates
10 Sep, 2024 - Study reveals population-wide immune setpoint for SARS-CoV-2 antibodies
10 Sep, 2024 - RSV Vaccinations Protect Older Seniors
10 Sep, 2024 - Top in ID: Nasal staph colonization and postoperative infections; future COVID-19 vaccines
10 Sep, 2024 - WHO International Standards for antibodies to HPV6 HPV11 HPV31 HPV33 HPV45 HPV52 and HPV58
10 Sep, 2024 - Work starts on a cancer vaccine for people with Lynch syndrome
09 Sep, 2024 - Vaccine hope for one in 400 people with genetic disorder that increases cancer risk
09 Sep, 2024 - Hepatitis C Vaccines Nearer with New Details about the Virus’s Envelope
09 Sep, 2024 - New Covid Antibody Could Be Key To Developing Be-All and End-All Vaccine
09 Sep, 2024 - Machine learning may lead to better flu vaccines
09 Sep, 2024
Clinical development
- Tonix Pharmaceuticals Announces That its Single Dose Mpox Vaccine Candidate TNX-801 Aligns with WHO’s Newly Issued Preferred Target Product Profile for Mpox Vaccines in Global Health Emergency
16 Sep, 2024 - 5 Late-Stage mRNA Vaccines to Watch
16 Sep, 2024 - A vaccine could become a ‘vital’ weapon against pancreatic cancer
16 Sep, 2024 - Breast cancer vaccine to enter clinical trial phase
16 Sep, 2024 - Experimental mRNA Cancer Vaccine Shows Promise in Patients With Advanced Cancers
16 Sep, 2024 - Researchers say lung cancer vaccine could come soon
15 Sep, 2024 - Cancer jab shows promise in early trial results
15 Sep, 2024 - Dr Jonathan Riess on the Potential of IO102-IO103, the Cancer Vaccine Landscape
14 Sep, 2024 - ICMR to advance 1st in-human trials for Zika, flu, blood cancer therapies
14 Sep, 2024 - Indian Immunologicals Sign Pact For Clinical Development Of Zika Vaccine
14 Sep, 2024 - ESMO: IO Biotech’s vaccine and Keytruda combo hits primary endpoint in phase 2 squamous cell carcinoma trial
14 Sep, 2024 - Experimental mRNA cancer vaccine shows potential for advanced stage cancer patients in Phase I trial
13 Sep, 2024 - Elicio Therapeutics Announces Three Upcoming Presentations Focused on its Lymph Node Targeted, mKRAS-Specific Amphiphile Vaccines
13 Sep, 2024 - CureVac’s CVGBM Cancer Vaccine Induces Promising Immune Responses in Phase 1 Study in Glioblastoma Presented at the ESMO 2024 Congress
13 Sep, 2024 - GSK presents positive mRNA seasonal influenza vaccine data
13 Sep, 2024 - ESMO: Moderna’s mRNA solid tumour vaccine shows early promise
13 Sep, 2024 - 130 lung cancer patients from six countries given experimental mRNA vaccine as study commences
13 Sep, 2024 - ‘Encouraging’ Early Data for mRNA Vaccine in Glioblastoma
13 Sep, 2024 - Q&A: Vaccine fails to prevent C. difficile infection but reduces symptom duration
13 Sep, 2024 - New vaccine shows promise in treating patients with advanced cancers
12 Sep, 2024 - Promising Lassa fever vaccine is headed to phase I clinical trial
12 Sep, 2024 - GSK’s HSV Vaccine Study Fails to Meet Primary Efficacy Goal
12 Sep, 2024 - Birmingham opens first pancreatic cancer mRNA vaccine trial in Europe
12 Sep, 2024 - Vaxxas launches Phase I trial for H7N9 influenza vaccine
12 Sep, 2024 - Monkey Pox vaccine: Bavarian Nordic’s smallpox vaccine found 58% effective after one dose
12 Sep, 2024 - GSK’s Phase I/II herpes simplex vaccine trial misses primary endpoint
12 Sep, 2024 - Merck’s Gardasil 9 vaccine meets primary endpoint in Phase 3 trial
12 Sep, 2024 - Another Herpes Vaccine Candidate Flops
12 Sep, 2024 - Doherty Clinical Trials to conduct trial of Australian-developed needle-free vaccine for avian influenza
12 Sep, 2024 - Moderna Focuses on Influenza – COVID Combination Vaccine Candidate
12 Sep, 2024 - Trial to assess personalized vaccine for aggressive brain tumors
12 Sep, 2024 - GSK Halts Herpes Simplex Virus Vaccine Development, Clears Path For Other Contenders Like Moderna, BioNTech
11 Sep, 2024 - Vaxxas Initiates Phase I Clinical Trial of Pre-Pandemic Avian Influenza A Virus (H7N9) Vaccine Delivered Using Vaxxas’ Novel High-Density Microarray Patch (HD-MAP)
11 Sep, 2024 - Versatope Launches Clinical Development Team for VT-105, a Pan-influenza A Vaccine Candidate
11 Sep, 2024 - Merck’s HPV vaccine meets key goals in Japanese study (NYSE:MRK)
11 Sep, 2024 - Chinese vaccine for mpox gets clearance for clinical trials
11 Sep, 2024 - Sanofi’s high-dose vaccine targets flu vulnerabilities in older adults
11 Sep, 2024 - Vaccination Protects Japanese Men from HPV Cancers
11 Sep, 2024 - China Approves Sinopharm’s Mpox Vaccine For Clinical Trials
10 Sep, 2024 - 2 new vaccines may be first step toward curing brain cancer
10 Sep, 2024 - 69% Overall Response Rate in Cancer Vaccine Candidate Phase 2 Study
10 Sep, 2024 - Chikungunya Vaccine Confirmed Effective and Safe
10 Sep, 2024 - Global Phase 3 Study Launches for Second-Line Non-Small Cell Lung Cancer Vaccine
10 Sep, 2024 - Vaccine trial volunteer works to empower her community, end HIV
09 Sep, 2024 - Evaxion’s cancer vaccine EVX-01 reports 69% response rate
09 Sep, 2024 - CureVac to present CVGBM glioblastoma cancer vaccine data at ESMO
09 Sep, 2024
Regulation & policy
- Changes coming to allow Alberta pharmacists to vaccinate kids under five
16 Sep, 2024 - The Taliban suspend polio vaccination campaign in Afghanistan
16 Sep, 2024 - DOH-6 warns public on unauthorized mpox vaccines
15 Sep, 2024 - Florida Discourages Use Of mRNA COVID-19 Vaccines In Older Adults Despite Cases Being High; Know Why
15 Sep, 2024 - CSL’s mRNA Covid-19 vaccine approved for sale in Japan
15 Sep, 2024 - MVA-BN prequalified as first effective vaccine against mpox
15 Sep, 2024 - ‘Astra Zeneca COVID-19 vaccine left us disabled – now we’re locked in a battle with a pharma giant’
14 Sep, 2024 - Japan approves updated Covid-19 vaccine to tackle JN.1 variant
13 Sep, 2024 - Florida advises against use of mRNA COVID vaccine heading into the fall and winter
13 Sep, 2024 - Korea to begin COVID-19 vaccination drive on Oct. 11
13 Sep, 2024 - Meiji Holdings Subsidiary Gains Vaccine Approval
13 Sep, 2024 - 21-Valent Pneumococcal Conjugate Vaccine Recommendations Updated
13 Sep, 2024 - For uninsured Wisconsinites, finding a free COVID-19 vaccine will be harder, now that a key federal program has ended
13 Sep, 2024 - Millions of children to be offered life-saving jab to protect against STI and eight types of cancer
12 Sep, 2024 - Moderna’s Covid-19 vaccine for ages 12 and older approved
12 Sep, 2024 - Project 2025 Would Eliminate No-Cost Vaccines for 54 Million Medicare Beneficiaries
11 Sep, 2024 - New Zealand Responds To Confirmed Mpox Cases With Vaccine Approval
11 Sep, 2024 - New guidelines for who should take RSV vaccine
11 Sep, 2024 - Kids to get measles jab earlier, tetanus shot later in updated vaccination program
11 Sep, 2024 - Pediatricians Highlight ACIP’s Role in COVID-19 Pandemic
10 Sep, 2024 - Denmark announces winter 2024 Covid-19 and influenza vaccination programmes
10 Sep, 2024 - Shingles Vaccine Now Available In Malaysia
10 Sep, 2024 - New COVID vaccines may be coming to Australia. Here’s what to know about the JN.1 shots
09 Sep, 2024 - New York State health commissioner allows pharmacists to administer mpox vaccine without prescription
09 Sep, 2024
Business
- Encephalitis Vaccination Market 2024 Key Indicators: Novartis, Sanofi, Chengdu Institute of Biological Products, Wuhan Institute of Biological Products
16 Sep, 2024 - Down More Than 50%, Is It Time to Buy Moderna Stock as the Biotech Charts a New Post-COVID Path?
15 Sep, 2024 - United States the End-To-End Vaccine Supply Chain Market By Application
15 Sep, 2024 - Nigeria’s Road To Vaccine Self-sufficiency: The Challenges, Prospects
15 Sep, 2024 - Vaccine Contract Manufacturing Market Size, Share, Trends & Forecast
14 Sep, 2024 - AstraZeneca: Treasury says ‘positive discussions’ ongoing over future of £450m vaccine plant
14 Sep, 2024 - Pediatricians cut back on COVID shots as interest wanes
14 Sep, 2024 - Facing stubborn manufacturing challenges
13 Sep, 2024 - French Vaccine Maker Valneva Raises €61M In Private Placing
13 Sep, 2024 - GSK announces launch of Herpes Zoster vaccine Shingrix in Malaysia
13 Sep, 2024 - Influenza Vaccine Market Set to Double to $13.9 Billion by 2033
13 Sep, 2024 - 13 Million Mpox Vaccines Can Be Produced
13 Sep, 2024 - Moderna stock plunges nearly 20% as company reports poor COVID-19 vaccine sales and cuts to research plans
12 Sep, 2024 - Bavarian Nordic eyes external partnerships in bid to produce tens of millions of mpox vaccine doses
12 Sep, 2024 - Moderna to launch skin cancer vaccine as soon as 2025
12 Sep, 2024 - Sanofi completes build out of $554M pandemic-ready modular plant for vaccines, biologics
12 Sep, 2024 - Bavarian Nordic promises two million mpox vaccines for Africa by end of 2024
12 Sep, 2024 - Brazil vaccine provider Beep raises $18 million, turns profitable
12 Sep, 2024 - GSK says mRNA flu shot shows promise in boost for pipeline
12 Sep, 2024 - Bharat Biotech, Alopexx partner to develop new broad-spectrum vaccine
11 Sep, 2024 - Interview: how we’re working to boost global cholera vaccine supply
11 Sep, 2024 - HK inno.N signs new Covid-19 vaccine supply agreement with Pfizer
11 Sep, 2024 - Colorado pediatricians struggling to get COVID-19 doses
10 Sep, 2024 - French firm Osivax grants rights to KM Biologics to develop and market influenza vaccine in Japan
10 Sep, 2024 - Adult Vaccine Market Forecasts Report and Competitive Landscape 2024-2032 Featuring GlaxoSmithKline, AstraZeneca, Sanofi Pasteur, Pfizer, and CSL
10 Sep, 2024 - GSK Shingles Vaccine Now Available In Malaysia
10 Sep, 2024 - Travel Vaccines Market Projected to See Significant Growth by 2031: Emerging Trends, Key Drivers, and Impact of COVID-19 on Global Travel Demand
10 Sep, 2024 - Big Pharma lacks motive to prep for new pandemics
10 Sep, 2024 - mRNA Vaccine Market Size to Achieve USD 9.6 Billion Revenue by 2034, Real-World Efficacy and Infrastructure Investments Boost Market Dynamics – Exclusive Report by Transparency Market Research, Inc.
09 Sep, 2024
0 Comments